Raúl Moreno
About
Raúl Moreno is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Raúl Moreno has authored 21 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raúl Moreno's work include Cardiac Valve Diseases and Treatments (7 papers), Coronary Interventions and Diagnostics (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Raúl Moreno is often cited by papers focused on Cardiac Valve Diseases and Treatments (7 papers), Coronary Interventions and Diagnostics (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Raúl Moreno collaborates with scholars based in Spain, United States and Netherlands. Raúl Moreno's co-authors include Guillermo Galeote, Santiago Jiménez‐Valero, Marc-André d’Entremont, José Ángel Cabrera, Goran Stanković, Gilles Montalescot, Jessica Tyrwhitt, Vicente Martín, Adolfo Fontenla and Timothy D. Henry and has published in prestigious journals such as The American Journal of Cardiology, American Heart Journal and Journal of Clinical Medicine.
In The Last Decade
Raúl Moreno
16 papers receiving 68 citations
Peers
Raúl Moreno
Silvia Leonardi Italy
Ramez M. Odat Jordan
Panayiotis Avraamides Cyprus
Serena Ledwidge United Kingdom
Pilar García-González Spain
Nadir Alpay Türkiye
Mehrdad Mahalleh Iran
Daniele Stella Italy
Vjola Jorgji United States
Michele Scarano Italy
Citations per year, relative to Raúl Moreno Raúl Moreno (= 1×)
peers
Silvia Leonardi
Countries citing papers authored by Raúl Moreno
Since
Specialization
Citations
This map shows the geographic impact of Raúl Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl Moreno more than expected).
Fields of papers citing papers by Raúl Moreno
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Raúl Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl Moreno. The network helps show where Raúl Moreno may publish in the future.
Co-authorship network of co-authors of Raúl Moreno
This figure shows the co-authorship network connecting the top 25 collaborators of Raúl Moreno. A scholar is included among the top collaborators of Raúl Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl Moreno. Raúl Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jurado‐Román, Alfonso, Ralf Birkemeyer, Oriol Rodríguez‐Leor, et al.. (2024). Meta‐long Papyrus: Meta‐analysis of mid to long‐term outcomes of PK Papyrus covered stent. Catheterization and Cardiovascular Interventions. 104(3). 492–498.
2.
Galán‐Arriola, Carlos, Claudia Pérez‐Martínez, Borja Ibáñez, et al.. (2024). ELLIS Study: Comparative Analysis of Excimer Laser Coronary Angioplasty and Intravascular Lithotripsy on Drug-Eluting Stent as Assessed by Scanning Electron Microscopy. Circulation Cardiovascular Interventions. 17(11). e014505–e014505.
3.
Moreno, Raúl, Vladimír Džavík, John Cairns, et al.. (2024). Stent thrombosis in the setting of ST-segment elevation acute myocardial infarction in the contemporary practice: results from the TOTAL randomized trial. Coronary Artery Disease. 36(2). 126–138.
4.
Fontenla, Adolfo, et al.. (2024). Red Blood Cell Distribution Width is a Biomarker of Red Cell Dysfunction Associated with High Systemic Inflammation and a Prognostic Marker in Heart Failure and Cardiovascular Disease: A Potential Predictor of Atrial Fibrillation Recurrence. High Blood Pressure & Cardiovascular Prevention. 31(5). 437–449.
5.
Alfonso, Fernándo, Tamaz Shaburishvili, Bruno Farah, et al.. (2024). First-in-man study of a novel everolimus-coated balloon for the treatment of coronary in-stent restenosis. Coronary Artery Disease. 36(2). 91–98.
6.
d’Entremont, Marc-André, Shun Fu Lee, Rajibul Mian, et al.. (2024). Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction. American Heart Journal. 275. 173–182.
7.
Jurado‐Román, Alfonso, et al.. (2024). Percutaneous Pulmonary Thrombectomy Beyond Acute Pulmonary Embolism: Removing Organized Thrombus in Subacute Massive Pulmonary Embolism. Journal of Endovascular Therapy. 32(6). 1796–1798.
8.
Jurado‐Román, Alfonso, et al.. (2024). Drug-Eluting Balloons in Calcified Coronary Lesions: A Meta-Analysis of Clinical and Angiographic Outcomes. Journal of Clinical Medicine. 13(10). 2779–2779.
9.
Moreno, Raúl, Rüdiger Smolnik, Luis Nombela‐Franco, et al.. (2024). Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial. Clinical Research in Cardiology. 114(3). 313–322.
10.
Domínguez, José Antonio Ruiz, et al.. (2024). Diagnosis of Congenital Heart Disease in Adulthood: How Often, How Relevant?. The American Journal of Cardiology. 231. 72–74.
11.
Amat‐Santos, Ignacio J., Javier Herrero, Pablo Piñón-Esteban, et al.. (2024). Impact of commissural alignment on the hemodynamic performance of supra‐annular self‐expandable transcatheter aortic valves. Catheterization and Cardiovascular Interventions. 104(5). 1060–1070.
12.
Jiménez‐Valero, Santiago, et al.. (2024). Severe acute recoil following transcatheter aortic valve replacement with a self-expanding prosthesis in a heavily calcified bicuspid aortic valve. Future Cardiology. 20(15-16). 823–826.
13.
López-Mínguez, José Ramón, Ángel L.M. de Francisco, María José Soler, et al.. (2023). Cost‐effectiveness analysis of dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain. Catheterization and Cardiovascular Interventions. 102(2). 233–240.
14.
Yamamoto, Masanori, Kentaro Hayashida, Christian Hengstenberg, et al.. (2023). Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation. The American Journal of Cardiology. 207. 150–158.
15.
Mehran, Roxana, Alessandro Spirito, James Jin, et al.. (2023). Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR. JACC Advances. 2(2). 100259–100259.
16.
Biscaglia, Simone, Andrea Erriquez, Matteo Serenelli, et al.. (2022). Complete versus culprit‐only strategy in older MI patients with multivessel disease. Catheterization and Cardiovascular Interventions. 99(4). 970–978.
17.
Jiménez‐Valero, Santiago, et al.. (2022). Subtle QRS changes are associated with reduced ejection fraction, diastolic dysfunction, and heart failure development and therapy responsiveness: Applications for artificial intelligence to ECG . Annals of Noninvasive Electrocardiology. 27(6). e12998–e12998.
18.
Álvarez, Ana Belén Cid, Oriol Rodríguez‐Leor, Raúl Moreno, José M. de la Torre Hernández, & Armando Pérez de Prado. (2019). Selección de lo mejor del año 2019 en cardiología intervencionista. REC CardioClinics. 55. 64–70.
19.
Caylà, Joan A., et al.. (2011). Concordancia de las pruebas de tuberculina e Interferón gamma en población reclusa. Revista Española de Sanidad Penitenciaria. 13(1). 15–20.
20.
Moreno, Raúl, et al.. (2002). Calcificaciones intratesticulares: significación clínica. Actas Urológicas Españolas. 26(2). 92–97.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Silvia Leonardi Breakdown of academic impact, for papers by Ramez M. Odat Breakdown of academic impact, for papers by Panayiotis Avraamides Breakdown of academic impact, for papers by Serena Ledwidge Breakdown of academic impact, for papers by Pilar García-González Breakdown of academic impact, for papers by Nadir Alpay Breakdown of academic impact, for papers by Mehrdad Mahalleh Breakdown of academic impact, for papers by Daniele Stella Breakdown of academic impact, for papers by Vjola Jorgji Breakdown of academic impact, for papers by Michele Scarano